Sleep Number (NASDAQ:SNBR - Get Free Report) had its price target decreased by Piper Sandler from $12.00 to $11.00 in a report released on Thursday,Benzinga reports. The firm presently has a "neutral" rating on the stock. Piper Sandler's target price suggests a potential upside of 45.31% from the company's previous close.
A number of other analysts have also recently commented on SNBR. StockNews.com raised Sleep Number from a "hold" rating to a "buy" rating in a research report on Thursday, January 9th. Wedbush dropped their price target on Sleep Number from $18.00 to $12.00 and set a "neutral" rating on the stock in a research report on Thursday.
Check Out Our Latest Research Report on Sleep Number
Sleep Number Stock Performance
Shares of SNBR traded up $0.08 during mid-day trading on Thursday, reaching $7.57. The company had a trading volume of 1,935,111 shares, compared to its average volume of 425,357. The firm has a 50-day moving average price of $15.81 and a 200 day moving average price of $15.69. Sleep Number has a 52 week low of $6.91 and a 52 week high of $20.75. The company has a market capitalization of $169.35 million, a price-to-earnings ratio of -4.18 and a beta of 2.14.
Hedge Funds Weigh In On Sleep Number
Several hedge funds and other institutional investors have recently added to or reduced their stakes in SNBR. Wealthfront Advisers LLC bought a new position in Sleep Number in the 4th quarter valued at approximately $14,861,000. Stadium Capital Management LLC lifted its position in Sleep Number by 30.3% in the 4th quarter. Stadium Capital Management LLC now owns 2,616,459 shares of the company's stock valued at $39,875,000 after acquiring an additional 608,092 shares in the last quarter. Hodges Capital Management Inc. lifted its position in Sleep Number by 146.6% in the 3rd quarter. Hodges Capital Management Inc. now owns 1,010,920 shares of the company's stock valued at $18,520,000 after acquiring an additional 601,005 shares in the last quarter. Formula Growth Ltd. lifted its position in Sleep Number by 31.8% in the 4th quarter. Formula Growth Ltd. now owns 485,206 shares of the company's stock valued at $7,395,000 after acquiring an additional 117,055 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in Sleep Number by 98.0% in the 4th quarter. JPMorgan Chase & Co. now owns 226,144 shares of the company's stock valued at $3,446,000 after acquiring an additional 111,915 shares in the last quarter. 85.67% of the stock is owned by institutional investors.
About Sleep Number
(
Get Free Report)
Sleep Number Corporation, together with its subsidiaries, offers sleep solutions and services in the United States. The company designs, manufactures, markets, retails, and services beds, pillows, sheets, and other bedding products under the Sleep Number name. It also provides smart adjustable bases under the FlextFit brand, and smart beds under the Climate 360 name.
Further Reading
Before you consider Sleep Number, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sleep Number wasn't on the list.
While Sleep Number currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
